-
Celebrating 20 Years of Progress in Lung Cancer Research and Treatment
Read time: 5 minutes.
This year marks 20 years since researchers made a key discovery that changed the face of lung cancer research and treatment.
By uncovering EGFR’s role in lung cancer, researchers...
IN THE SPOTLIGHT
-
Eating Healthy on the Mediterranean Diet
Read time: 3 minutes. Oncology dietitian Lori Bumbaco takes us on a culinary journey, exploring why experts consistently rank the Mediterranean diet as the number one choice for... -
Small Cell SMASHERS Fireside Chat with Dr. Triparna Sen
Join us for a Facebook Live on Friday, November 1, as Triparna Sen, PhD, Icahn School of Medicine at Mount Sinai, discusses the biology and the role of biomarkers in small cell... -
Small Cell Lung Cancer: Highlights from WCLC and ESMO 2024
This is the second blog in our series of updates from the World Conference on Lung Cancer (WCLC), held in San Diego from September 7-10, and the European Society for Medical... -
Small Cell SMASHERS Fireside Chat with Dr. Christine Lovly - Video
Missed the Facebook Live? Watch the video! On Tuesday, October 8, Christine Lovly, MD, PhD, discussed the importance of clinical trials and the role of translational research in... -
How Do Drugs Get Approved (and Fast-Tracked) by the FDA?
Read time: 5 minutes. This is Part 3 in our series on how drugs get approved to treat lung cancer. Part 1: Understanding Clinical Trials - Why Are They Important for Drug... -
How We Define Success for a Clinical Trial
Read time: 6 minutes. This is Part 2 of 3 in our series on how drugs get approved to treat lung cancer. Make sure to read Part 1 on the phases of clinical trials and why they are... -
Understanding Clinical Trials: Why Are They Important for Drug Development?
Read time: 3 minutes. This is Part 1 in a 3-part series explaining how new drugs and treatments get approved to treat lung cancer. Parts 2 and 3 will be published in the coming... -
How Can Patients and Researchers Design Clinical Trials Together?
Read time: 2 minutes. Traditionally, people associate getting involved in lung cancer research with enrolling in a clinical trial. But most don’t realize they can also partner with... -
SCLC Virtual Meetup
SCLC patients/survivors - Join us the 3rd Wednesday of every month to c onnect with others who share common experiences and build your community. Register in advance for this...
How Nina’s Clinical Trial Led to a High-Five Celebration
How Nina’s Clinical Trial Led to a High-Five Celebration
Her doctor was excited, which made Nina excited. They high-fived and couldn’t believe the progress that had been made in just a few weeks. The clinical trial was already having positive effects. Before her clinical trial success, Nina went through the standard treatments for people with small-cell lung cancer (SCLC). She was diagnosed in early 2014, and the plan was to try different chemo and radiation therapies.But, after 14 months of treatment with side-effects, it became clear the standard…
Let Your Voice Be Heard!
Let Your Voice Be Heard!
We are collecting stories from patients, caregivers, friends, and family members! Tell us how lung cancer has affected your life. Email your story to us at support@lungevity.org. Thanks!
One Patient's SCLC Journey
One Patient's SCLC Journey
Learn about small cell lung cancer through the eyes of a patient and his oncologist. Dr. Christine Lovly, internationally recognized medical oncologist, and Jeff Lackey, an SCLC survivor, discuss their journey, the importance of lung cancer screening, and key considerations when someone is newly diagnosed.
This session is moderated by Amy Moore, PhD, LUNGevity's Vice President of Global Engagement and Patient Partnerships. Christine M. Lovly, MD, PhD, is Associate Professor of Medicine…